Reuters logo
BRIEF-Novavax Inc says positive top-line data from RSV F-protein vaccine clinical trial in older adults
August 10, 2015 / 8:05 PM / 2 years ago

BRIEF-Novavax Inc says positive top-line data from RSV F-protein vaccine clinical trial in older adults

Aug 10 (Reuters) - Novavax Inc :

* Positive top-line data from phase 2 RSV F-protein vaccine clinical trial in older adults

* Trial showed statistically significant vaccine efficacy in prevention of symptomatic rsv disease in older adults

* RSV F vaccine was well-tolerated and fulfilled co’s expectations of primary, secondary and exploratory objectives of trial Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below